Bladder Cancer

Latest Bladder Cancer News

Smoking Tied to Worse Bladder Cancer Outcomes After Surgery

Publish Date October 14, 2020

Poor outcomes include lower response rate to chemotherapy, higher mortality, recurrence.

Radiation for Abdominal, Pelvic Cancers Ups Secondary Sarcoma Risk

Publish Date October 5, 2020

Compared with patients who undergo surgery alone for abdominal or pelvic cancers, those who receive radiation and chemotherapy are at elevated risk for secondary sarcomas.

First-Line Avelumab Maintenance Ups Survival in Urothelial Carcinoma

Publish Date September 21, 2020

Avelumab improves overall and progression-free survival among patients with unresectable locally advanced or metastatic urothelial carcinoma whose disease has not progressed while on first-line chemotherapy.

PPI Use Is Negative Prognostic Marker in Urothelial Cancer

Publish Date September 18, 2020

PPI use linked to significantly worse progression-free, overall survival in advanced urothelial cancer.

Data Support Ureteroscopy for Upper Tract Urothelial Carcinoma

Publish Date August 26, 2020

Patients who underwent ureteroscopic management of low-risk UTUC had a 5-year cancer-specific survival rate of 92.6%.

Acalabrutinib Plus Pembrolizumab Failed to Improve Outcomes in Relapsed mUC

Publish Date August 19, 2020

The purpose of this trial was to determine if suppression of MDSCs with acalabrutinib could enhance pembrolizumab activity safely in this population.

Survival Remains Poor in High-Risk Muscle-Invasive Urothelial Carcinoma

Publish Date August 18, 2020

Overall and disease-free survival among patients undergoing surgical resection for MIUC is low despite increasing use of neoadjuvant chemotherapy.

MRI Useful for Diagnosing Muscle-Invasive Bladder Cancer

Publish Date August 6, 2020

Multiparametric magnetic resonance imaging is highly accurate in differentiating nonmuscle-invasive from muscle-invasive bladder cancer, according to a new systematic review and meta-analysis.

High Long-Term Death Risk From Muscle-Invasive Bladder Cancer Reported

Publish Date July 20, 2020

The 20-year mortality rate among patients with muscle-invasive bladder cancer is 71%, according to a study of Swedish patients. Investigators who analyzed a large population-based cohort of patients with bladder cancer that had more than 20 years of follow-up found that muscle-invasive bladder cancer (MIBC) results in a high risk of cancer-specific death, according to…

Bavencio Approved for First-Line Urothelial Carcinoma Maintenance Treatment

Publish Date July 2, 2020

The FDA has approved Bavencio® (avelumab; EMD Serono) for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma that has not progressed with first-line platinum-containing chemotherapy.